4 completed, 3 unknown, 2 active not recruiting, 1 recruiting. 2 Not applicable, 2 Phase 2, 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Chronic Kidney Disease Stage 2: new trials by email Literature Review of Chronic Kidney Disease Stage 2 trials Research Report on Chronic Kidney Disease Stage 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis) Vonafexor low dose, Vonafexor high dose - Chronic Kidney Disease Stage 2, Chronic Kidney Disease Stage 3 | Phase 2 | Terminated | Enyo Pharma | 10 | 2025-07-01 | 2026-04-23 |
| Preserving Kidney Function in Children With Chronic Kidney Disease Blood pressure, Urine protein - Chronic Kidney Disease Stage 2, Chronic Kidney Disease Stage 3 | Completed | Children's Hospital of Philadelphia | 20240 | 2023-09-22 | 2024-08-16 | |
| Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD GLP-1 receptor agonist, SGLT2 inhibitor, Tirzepatide - Chronic Kidney Disease stage3, Chronic Kidney Disease stage4 | Recruiting | Cardenal Herrera University | 250 | 2023-09-15 | 2025-12-30 | |
| The Effect of Vitamin D3 Supplementation on Hepcidin and Ferritin Serum Levels in Children With Chronic Kidney Disease Vitamin D - Chronic Kidney Disease Stage 1, Chronic Kidney Disease Stage 2 | Phase 2 / Phase 3 | Completed | Hasanuddin University | 43 | 2023-05-01 | 2024-11-27 |
| Prospective Decision Impact Trial of KidneyIntelX KidneyIntelX - Diabetic Kidney Disease, Chronic Kidney Disease Stage 1 | Active not recruiting | Renalytix AI, Inc. | 2000 | 2021-11-22 | 2026-08-13 | |
| Prospective Decision Impact Clinical Utility Trial of KidneyIntelX KidneyIntelX - Diabetic Kidney Disease, Chronic Kidney Diseases | Active not recruiting | Renalytix AI, Inc. | 2000 | 2021-11-01 | 2026-08-13 | |
| Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management My Kidney Guru - Chronic Kidney Diseases, Chronic Kidney Disease stage3 | Not applicable | Completed | 3-C Institute for Social Development | 67 | 2021-09-01 | 2022-11-30 |
| The Life Style Patterns and the Development Trend of Chronic Diseases in Healthy and Sub-healthy Groups Were Analyzed by Using Data-mining Techniques Chronic Kidney Disease Stage 1, Chronic Kidney Disease Stage 2 | Unknown | Far Eastern Memorial Hospital | 81108 | 2021-03-03 | 2022-05-10 | |
| Application of Wearable Devices to Build a Self-Management Model in Chronic Kidney Disease Patients Mobile health application and social media - Chronic Kidney Disease Stage 1, Chronic Kidney Disease Stage 2 | Not applicable | Completed | National Taiwan University Hospital | 49 | 2019-01-13 | 2021-08-26 |
| Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2 Calcitriol, placebo - Chronic Kidney Disease Stage 1, Chronic Kidney Disease Stage 2 | Phase 4 | Unknown | Taixing People's Hospital | 300 | 2015-07-01 | 2015-06-08 |
| N-Acetyl Cystein and Contrast Nephropathy Oral N-Acetyl Cystein, IV N-Acetyl Cystein, Placebo group - Chronic Kidney Disease Stage 2, Radiographic Contrast Agent Nephropathy | Phase 3 | Unknown | Imam Khomeini Hospital | 549 | 2013-03-01 | 2013-03-28 |
Renal Insufficiency, Chronic (11) · Diabetic Nephropathies (2) · Bronchiolitis Obliterans Syndrome (1) · Chronic Disease (1) · Diabetes Mellitus, Type 2 (1) · Hypertension (1) · Inflammation (1) · Lymphoma, Follicular (1) · Metabolic Syndrome (1) · Obesity (1) · Proteinuria (1) · Vascular Calcification (1)
Disease Attributes (11) · Female Urogenital Diseases (11) · Female Urogenital Diseases and Pregnancy Complications (11) · Kidney Diseases (11) · Male Urogenital Diseases (11) · Pathologic Processes (11) · Pathological Conditions, Signs and Symptoms (11) · Renal Insufficiency (11) · Urogenital Diseases (11) · Urologic Diseases (11) · Chronic Disease (10) · Diabetes Mellitus (3) · Endocrine System Diseases (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3)
Angiotensin-Converting Enzyme Inhibitors (1) · Blood Pressure (1) · Calcitriol (1) · Canagliflozin (1) · Exenatide (1) · Liraglutide (1) · Metformin (1) · Sodium-Glucose Transporter 2 Inhibitors (1) · Tirzepatide (1) · Vitamin D (1) · dapagliflozin (1) · dulaglutide (1) · empagliflozin (1) · semaglutide (1)
Renalytix AI, Inc. (2) · 3-C Institute for Social Development (1) · Cardenal Herrera University (1) · Children's Hospital of Philadelphia (1) · Enyo Pharma (1) · Far Eastern Memorial Hospital (1) · Hasanuddin University (1) · Imam Khomeini Hospital (1) · National Taiwan University Hospital (1) · Taixing People's Hospital (1)
United States (4) · Taiwan (2) · China (1) · Germany (1) · Indonesia (1) · Iran (1) · Spain (1)
Ali Kazemi-Saeid, MD (1) · Ana Checa-Ros, MD, PhD (1) · Andi Muldiana Dwi Rachmayani, MD (1) · Chris Forrest, MD (1) · David W Lam, MD (1) · Debra Childress, PHD (1) · Ebrahin Kassaian, MD (1) · Luis D'Marco, MD, PhD (1) · Maria Ferris, MD, PHD, MPH (1) · Michelle Denburg, MD (1) · Mohammad R Khatami, MD (1) · Mojtaba Salarifar, MD (1) · Wen-Yi Li (1)
2023 (1)